Switch to:
More From Other Websites
IRIDEX' Total Glaucoma Solution Campaign for US Market to Debut at Annual Congress of the American... Apr 16 2015
IRIDEX CORP Financials Apr 08 2015
IRIDEX CORP Files SEC form 10-K, Annual Report Apr 02 2015
IRIDEX Granted U.S. Patent for Disposable Device for Efficient and Predictable Wound Closure in Eye... Mar 30 2015
IRIDEX Granted U.S. Patent for Disposable Device for Efficient and Predictable Wound Closure in Eye... Mar 30 2015
IRIDEX Announces First Commercial Sales of New Cyclo G6™ Glaucoma Laser Systems Mar 17 2015
IRIDEX Announces First Commercial Sales of New Cyclo G6™ Glaucoma Laser Systems Mar 17 2015
IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers Mar 09 2015
IRIDEX Reports 2014 Fourth Quarter, Year-End Results Mar 05 2015
Iridex posts 4Q profit Mar 05 2015
Iridex posts 4Q profit Mar 05 2015
IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today Mar 05 2015
IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Mar 05 2015
IRIDEX Reports 2014 Fourth Quarter, Year-End Results Mar 05 2015
Q4 2014 IRIDEX Corp Earnings Release - Time Not Supplied Mar 05 2015
IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date Feb 26 2015
IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date Feb 26 2015
IRIDEX To Debut Cyclo G6™ Glaucoma Laser Platform and Present New Clinical Data at the American... Feb 23 2015
IRIDEX To Debut Cyclo G6™ Glaucoma Laser Platform and Present New Clinical Data at the American... Feb 23 2015
IRIDEX Receives FDA Clearance for Cyclo G6™ Laser System for the Treatment of Multiple Stages of... Feb 02 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK